19 December 2017 During the last chat of the year, we remembered and honored those who are no longer with us. In addition, #BCSM co-founder @stales reviewed the top breast […]
Read more ›
Dr. Shelley Hwang from Duke University spoke on DCIS subtyping and overtreatment. She noted that DCIS now comprises over 20% of all mammographically detected breast cancer. It is considered a […]
Read more › This guest post is from Dr. Aleksandra Popadich. Dr. Popadich came all the way to Las Vegas from New Zealand because she watched Dr. Attai’s tweets from the 2016 conference! Oncoplastic […]
Read more › ASBrS17: Contralateral Prophylactic Mastectomy (CPM) This guest post is by Dr. Diane Radford. The American Society of Breast Surgeons published a consensus statement on CPM in which it was stated […]
Read more › Thank you to Dr. Kimberli Cox for submitting this review of the Lymphedema Panel at ASBRS 2017. The panel, a multidisciplinary (breast surgeons, plastic surgeons, radiation oncology, LE therapists, PMR […]
Read more ›